NSHRF yields 8000.00% · PFE yields 6.13%● Live data
📍 NSHRF pulled ahead of the other in Year 1
Combined, NSHRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NSHRF + PFE for your $10,000?
Northern Shield Resources Inc., a natural resource company, engages in identifying, acquiring, and exploring mineral properties primarily in Eastern Canada. The company primarily explores for nickel, copper, gold, silver, and platinum group elements. It principally holds 88.5% interests in the Shot Rock property with 750 claims covering an area of 121 square kilometers located in Nova Scotia; 100% interests in the Huckleberry property comprising 72 claims with an area of 54 square kilometers located in north of Schefferville, Quebec; and 100% interests in the Idefix property with 40 claims covering an area of 18 square kilometers located in Labrador Trough, Québec. The company also holds an option agreement to acquire a 100% interest in the Merasheen property with 217 claims covering an area of 54 square kilometers located at the southern end of Merasheen Island in Placentia Bay, Newfoundland. Northern Shield Resources Inc. was founded in 1999 and is headquartered in Ottawa, Canada.
Full NSHRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.